Armistice Capital »

Nevro shares owned by Armistice Capital

Quarter-by-quarter ownership of Nevro (NVRO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nevro

Tip: Access up to 7 years of quarterly data

All positions including Nevro held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nevro by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $66M 3.5M 19.22
2023-06-30 $60M 2.4M 25.42

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Nevro

Vanguard Group
Arrowpoint Asset Management
Engaged Capital
Fred Alger Management
Braidwell
D. E. Shaw & Co
Goldman Sachs Group
Millennium Management
Palo Alto Investors
Principal Financial Group
Balyasny Asset Management
Two Sigma Advisers
Two Sigma Investments
Federated Investors
Credit Suisse

View all funds holding Nevro